Articles

Smartphone apps evaluated by researchers returned highly variable and often inaccurate feedback. Read More ›

According to recent study results, potentially lethal blood clots still develop in patients within the first month following colorectal surgery despite the use of clot-prevention treatments. Read More ›

Researchers tested the DNA of more than 300 women and discovered a “genetic marker” method that helps determine which women are prone to breast cancer recurrence years later. Read More ›

Women who have a tubal ligation are at an increased risk for cervical cancer due to less frequent Pap smears. Read More ›

New recommendations released by the American Cancer Society are based on evidence garnered from a review of the National Lung Screening Trial. Read More ›

When compared with a single measurement of prostate specific antigen, measurements taken over time improve accuracy when detecting aggressive prostate cancer. Read More ›

People who smoke more frequently have a greater chance of developing more aggressive and deadly bladder cancer. Read More ›

As cancer treatments emerge in pill form, patients meet many challenges when administering their own chemotherapy outside the supervised cancer clinic environment. Read More ›

This is the first article in a 4-part series on bendamustine. This article describes the history and characterization of bendamustine. Subsequent articles will discuss the efficacy and safety of bendamustine in registration studies and describe ongoing clinical investigations of bendamustine. Read More ›

Bendamustine has an interesting history that spans more than 50 years. Bendamustine was first synthesized in the early 1960s in the former East Germany. It was first used to treat multiple myeloma and was subsequently extended to patients with chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL), and Hodgkin lymphoma. Read More ›